PCR Test - standard COVID-19 test provided by the NHS and approved by all countries
Polymerase chain reaction (PCR) is an efficient and cost-effective way to copy or “amplify” small segments of DNA or RNA.
Using PCR, millions of copies of a section of DNA are made in just a few hours, yielding enough DNA required for analysis. This innovative yet simple method allows clinicians to diagnose and monitor diseases using a minimal amount of sample, such as blood or tissue.
What is PCR?
Sample preparation Though PCR occurs in vitro, or outside of the body in a laboratory, it is based on the natural process of DNA replication. In its simplest form, the reaction occurs when a DNA sample and a DNA polymerase, nucleotides, primers and other reagents (man-made chemical compounds) are added to a sample tube. The reagents facilitate the reaction needed to copy the DNA code.
In addition to detecting diseases in a sample, PCR enables the monitoring of the amount of a virus present, or viral load, in a person’s body. In diseases such as hepatitis C or human immunodeficiency virus (HIV) infections, viral load is a good indication of how sick a person may be or how well a person’s medicine and treatment is working. Armed with this information, physicians may determine when to start treatment and the person’s response to treatment, making treatment personalized to each individual.
There are three clear steps in each PCR cycle, and each cycle approximately doubles the amount of target DNA. This is an exponential reaction so more than one billion copies of the original or “target” DNA are generated in 30 to 40 PCR cycles.
The Anti-SARS-CoV-2 serology test can support the detection of antibodies against SARS-CoV-2 in patients who have been exposed to the virus which causes COVID-19
The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions
The benefit of having a SARS-CoV-2 antibody test
Antibody tests are crucial for patient contact tracing, defining previous exposure, and for epidemiological studies. Epidemiological studies are urgently needed to help uncover the spread and burden of disease, in particular, the rate of asymptomatic infections, and to get better estimates on morbidity and mortality. This test may also be used together with molecular tests, like Roche’s cobas® SARS-CoV-2 PCR test, to aid in the diagnosis of suspected COVID-19 patients. As more is understood about immunity to SARS-CoV-2, it may help to assess who has built up immunity to the virus helping healthcare providers better manage patients.
Features and benefits of the SARS-CoV-2 Antibody Test
The SARS-CoV-2 Antibody Test can help relieve the burden on healthcare infrastructure generally by making reliable accurate testing possible in decentralised locations, complementing laboratory diagnostics and enabling effective screening. This allows for widespread mass screening without the need to over-burden specialist staff and laboratories. Patients can get a quick and convenient answer that in combination with local and national policies will help them modify their behaviour and help contain the virus and optimise restriction strategies. Follow-up appointments between patients and doctors to discuss the test results can be avoided.
SARS-CoV-2 Rapid Antigen Test
Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2
An aid in identifying individuals infected by SARS-CoV-2
The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatopgraphic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx.
This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19. This product is strictly intended for professional use in laboratory and Point of Care environment.
The benefit of having a SARS-CoV-2 antigen test available
The SARS-CoV-2 virus causes respiratory tract infection. It is transmitted mainly via respiratory droplets after close contact, and primary viral replication is presumed to occur in mucosal epithelium of the upper respiratory tract (nasal cavity and pharynx). At these locations viral load peaks within the first week after symptom onset, and then declines.
A SARS-CoV-2 antigen test detects the presence of the SARS-CoV-2 virus from part of the upper respiratory tract swab specimens by identifying a nucleoprotein that is carried by the virus. The test identifies current infection during the acute phase of COVID-19, while the virus is still present in large quantities in the respiratory tract.
If you want to minimise disruption to business as well as reduce absenteeism due self-isolation the corporate testing is the answer for you. It will also identify those who have been in contact with COVID-19 positive individuals.
Accurate COVID-19 testing administered by healthcare professionals at your workplace. 24 hr results delivered by email. Get back to work.
Find out if your team members have COVID-19 or if they’ve had it and developed an immune response.
Testing in your office and outside the office.
We will set up in your office and test up to 1000 team members per day.
We can also come to your construction site, care home or any other business .
Contact us for more information: